4-benzyl-2-methyl-1-2-4-thiadiazolidine-3-5-dione and Renal-Insufficiency--Chronic

4-benzyl-2-methyl-1-2-4-thiadiazolidine-3-5-dione has been researched along with Renal-Insufficiency--Chronic* in 1 studies

Other Studies

1 other study(ies) available for 4-benzyl-2-methyl-1-2-4-thiadiazolidine-3-5-dione and Renal-Insufficiency--Chronic

ArticleYear
Klotho suppresses the renin-angiotensin system in adriamycin nephropathy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2017, May-01, Volume: 32, Issue:5

    Klotho protein interacts with the transforming growth factor β (TGF-β) receptor and Wnt, which contribute to the progression of renal disease, inhibiting their signals. Renal and circulating klotho levels are diminished in chronic kidney disease.. Experiments were performed to assess whether supplementation of klotho protein could have protective effects on the kidney. Rats were injected with adriamycin (5 mg/kg) and divided into three groups: those treated with vehicle, those treated with klotho protein and those treated with klotho plus 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD). Rats without adriamycin treatment were used as a control.. Adriamycin reduced the serum klotho concentration and renal expression of klotho and E-cadherin. Adriamycin also increased the renal expression of Wnt, TGF-β, and angiotensinogen, as well as the renal abundance of β-catenin and angiotensin II. Klotho supplementation suppressed adriamycin-induced elevations of β-catenin and angiotensin II with sustained Wnt expression. Combined treatment with klotho and TDZD reversed the klotho-induced improvements in the renal abundance of β-catenin and angiotensin II as well as the expression of TGF-β and angiotensinogen without affecting E-cadherin.. Our data indicate that Wnt is involved in the pathogenesis of adriamycin nephropathy. Furthermore, klotho supplementation inhibited Wnt signaling, ameliorating renal angiotensin II. Finally, klotho protein appears to suppress epithelial-mesenchymal transition by inhibiting TGF-β and Wnt signaling.

    Topics: Animals; Antibiotics, Antineoplastic; beta Catenin; Cadherins; Doxorubicin; Epithelial-Mesenchymal Transition; Glucuronidase; Glycogen Synthase Kinase 3; Klotho Proteins; Male; Rats; Rats, Wistar; Receptors, Transforming Growth Factor beta; Renal Insufficiency, Chronic; Renin-Angiotensin System; Signal Transduction; Thiadiazoles

2017